Medindia1h
Eli Lilly's Zepbound to Dominate Global Obesity Market
Eli Lilly's Zepbound is set to dominate the global obesity market, offering new hope with its groundbreaking treatment for ...
Sleep apnea? Neuro implants promise good night’s rest
WAKE-UP CALL: 104m Indians or 11% of the population suffer from obstructive sleep apnea, according to a 2023 AIIMS study ...
GLP-1 questions emerge for 2025
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...
MATT RIDLEY: Move over, Ozempic: Why an astonishing new class of weight-loss drugs will soon end obesity FOR EVER - and here are the other surprising illnesses t…
Imagine if you could eat your fill on Christmas day then dial down your appetite for January. Good news: such a prospect may ...
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Wine Spectator23h
Top Wine and Health Stories of 2024
As in years past, wine and digestive health was a popular topic in 2024. We considered the effects of low-sulfur wines and ...